Abstract
A series of new spirooxindolocarbamates 4a–l and 6a–d were synthesized by using the Betti reaction. All the target compounds were well characterized by IR, NMR and mass spectrometry. The structures of the compounds 4a and 4e were confirmed by the single crystal X-ray diffraction. The in vitro antibacterial activity results revealed that the compounds 4f exhibited excellent antibacterial activity against E. coli with MIC value 7.5 µg/mL when compared with the standard drug ciprofloxacin with MIC value 9.25 µg/mL. The compounds 4l and 6c exhibit significant inhibiting activity against E. Coli with MIC values 10.5 µg/mL and 9.5 µg/mL, respectively. The compounds 4c and 4e showed significant activity against S. aureus with MIC value 10.5 µg/mL. The compounds 4a and 4f were exhibited moderate antifungal activity against A. niger with MIC values 17.5 µg/mL and 18.0 µg/mL, respectively. The compounds 4f and 4l exhibited the potent antioxidant activity with IC50 values 9.12 ± 0.01 µM and 7.06 ± 0.78 µM, respectively.
Graphic abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11030-019-10017-w/MediaObjects/11030_2019_10017_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11030-019-10017-w/MediaObjects/11030_2019_10017_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11030-019-10017-w/MediaObjects/11030_2019_10017_Sch1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11030-019-10017-w/MediaObjects/11030_2019_10017_Sch2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11030-019-10017-w/MediaObjects/11030_2019_10017_Fig2_HTML.png)
Similar content being viewed by others
References
Dandia A, Khan S, Soni P, Indora A, Mahawar DK, Pandya P, Chauhan CS (2017) Diversity-oriented sustainable synthesis of antimicrobial piropyrrolidine/thiapyrrolizidine oxindole derivatives: new ligands for a metallo-b-lactamase from Klebsiella pneumonia. Bioorg Med Chem Lett 27:2873–2880. https://doi.org/10.1016/j.bmcl.2017.04.083
Arun Y, Saranraj K, Balachandran C, Perumal PT (2014) Anticancer activity of ruthenocenyl chalcones and their molecular docking studies. Eur J Med Chem 74:50–64. https://doi.org/10.1016/j.ejmech.2013.12.027
Nabid MR, Rezaei SJT, Ghahremanzadeh R, Bazgir A (2010) Ultrasound-assisted one-pot, three-component synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-diones. Ultrason Sonochem 17:159–161. https://doi.org/10.1016/j.ultsonch.2009.06.012
Sridharan V, Karthikeyan K, Muthusubramanian S (2006) Unexpected multicomponent reaction of 2/4-methoxyarylaldehydes with arylhydroxylamines and maleic anhydride: a novel synthesis of unsymmetrical diarylamines. Tetrahedron Lett 47:4221–4223. https://doi.org/10.1016/j.tetlet.2006.04.043
Nishtala VB, Nanubolu JB, Basavoju S (2017) Ultrasound-assisted rapid and efficient one-pot synthesis of furanyl spirooxindolo and spiroquinoxalinopyrrolizidines by 1,3-dipolar cycloaddition: a green protocol. Res Chem Intermed 43:1365–1381. https://doi.org/10.1007/s11164-016-2703-8
Singh GS, Desta ZY (2012) Isatins as privileged molecules in design and synthesis of spiro-fused cyclic frameworks. Chem Rev 112:6104–6155. https://doi.org/10.1021/cr300135y
Chandam DR, Patravale AA, Jadhav SD, Deshmukh MB (2017) Low melting oxalic acid dihydrate: proline mixture as dual solvent/catalyst for synthesis of spiro[indoline-3,9′-xanthene]trione and dibarbiturate derivatives. J Mol Liq 240:98–105. https://doi.org/10.1016/j.molliq.2017.05.070
Barakat A, Islam MS, Ghawas HM, Majid AMA, Senduny FFE, Badria FA, Elshaier YAMM, Ghabbour HA (2019) Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2–p53 interaction. Bioorg Chem 86:598–608
Pogaku V, Krishna VS, Sriram D, Rangan K, Basavoju S (2019) Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1,2,4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines. Bioorg Med Chem Lett. https://doi.org/10.1016/j.bmcl.2019.04.026
Chandralekha E, Thangamani A, Valliappan R (2013) Ultrasound-promoted regioselective and stereoselective synthesis of novel spiroindanedionepyrrolizidines by multicomponent 1,3-dipolar cycloaddition of azomethine ylides. Res Chem Intermed 39:961–972. https://doi.org/10.1007/s11164-012-0608-8
Chen G, Yang J, Gao S, Zhang Y, Hao X (2015) Theoretical study of regioselectivity in the synthesis of spiro [pyrrolidine-2,3′-oxindole] compounds by [3 + 2] cycloaddition. Res Chem Intermed 41:4987–4996. https://doi.org/10.1007/s11164-014-1582-0
Dibenedetto A, Aresta M, Fragale C, Narracci M (2002) Reaction of silylalkylmono- and silylalkyldi-amines with carbon dioxide: evidence of formation of inter- and intra-molecular ammonium carbamates and their conversion into organic carbamates of industrial interest under carbon dioxide catalysis. Green Chem 4:439–443. https://doi.org/10.1039/B205319P
Gupte SP, Shivarkar AB, Chaudhari PV (2001) Carbamate synthesis by solid-base catalyzed reaction of disubstituted ureas and carbonates. Chem Commun 24:2620–2621. https://doi.org/10.1039/B107947F
Martin LL, Davis L, Klein JT, Nemoto P, Olsen GE, Bores GM, Camacho F, Petko WW, Rush DK, Selk D, Smith CP, Vargas HM, Winslow JT, Effland RC, Fink DM (1997) Synthesis and preliminary structure-activity relationships of 1-[(3-fluoro-4-pyridinyl)amino]-3-methyl-1H-indol-5-yl methyl carbamate (p10358), a novel acetylcholinesterase inhibitor. Bioorg Med Chem Lett 7:157–162. https://doi.org/10.1016/S0960-894X(96)00592-6
Vagner J, Qu H, Hruby VJ (2008) Peptidomimetics, a synthetic tool of drug discovery. Curr Opin Chem Biol 12:292–296. https://doi.org/10.1016/j.cbpa.2008.03.009
Nowick JS (2006) What I have learned by using chemical model systems to study biomolecular structure and interactions. Org Biomol Chem 4:3869–3885. https://doi.org/10.1039/B608953B
Liskamp RM, Rijkers DT, Kruijtzer JA, Kemmink J (2011) Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics. Chem Bio Chem 12:1626–1653. https://doi.org/10.1002/cbic.201000717
Cho CY, Moran EJ, Cherry SR, Stephans JC, Fodor SP, Adama CL, Sundaram A, Jacobs JW, Schultz PG (1993) An unnatural biopolymer. Science 261:1303–1305. https://doi.org/10.1126/science.7689747
Ghosh AK, Brindisi M (2015) Organic carbamates in drug design and medicinal chemistry. J Med Chem 58:2895–2940. https://doi.org/10.1021/jm501371s
Mousa SA, DeGrado WF, Mu DX, Kapil RP, Lucchesi BR, Reilly TM (1996) Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist. Circulation 93:537–543. https://doi.org/10.1161/01.CIR.93.3.537
Xue CB, Wityak J, Sielecki TM, Pinto DJ, Batt DG, Cain GA, Sworin M, Rockwell AL, Roderick JJ, Wang S, Orwat MJ, Frietze WE, Bostrom LL, Liu J, Higley CA, Rankin FW, Tobin AE, Emmett G, Lalka GK, Sze JY, Meo SVD, Mousa SA, Thoolen MJ, Racanelli AL, Hausner EA, Reilly TM, DeGrado WF, Wexler RR, Olson RE (1997) Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists. J Med Chem 40:2064–2084. https://doi.org/10.1021/jm960799i
Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T, Nakanishi O (1999) A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA 96:4592–4597
Williams BR, Nazarians A, Gill MA (2003) A review of rivastigmine: a reversible cholinesterase inhibitor. Clin Ther 25:1634–1653. https://doi.org/10.1016/S0149-2918(03)80160-1
Emre M, Aarsland D, Albanese A, Byrne EJ, Deusch G, Deyn PPD, Durif F, Kulisevsky J, Laar TV, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R (2004) Rivastigmine for dementia associated with Parkinson’s disease. N Engl J Med 351:2509–2518. https://doi.org/10.1056/NEJMOA041470
Best BM, Goicoechea M (2008) Efavirenz—still first-line king? Exp Opin Drug Metab Toxicol 4:965–972. https://doi.org/10.1517/17425255.4.7.965
Madero JS, Keever AV, Mendez P, Gomez JLM, Escobar IT, Escolano FG, Kasusky IJ, Aquino MM, Santos CR, Saleme LP, Frausto SR, Puente BA, Ramirez LES, Lima V, Zamudio FB, Ramirez BC, Montaner J (2010) Prospective, randomized, open label trial of Efavirenz vs Lopinavir/Ritonavir in HIV + treatment-naive subjects With CD4 + <200 cell/mm3 in Mexico. J Acquir Immune Defic Syndr 53:582–588. https://doi.org/10.1097/QAI.0b013e181cae4a1
Phipatanakul W, Eggleston PA, Walker CMK, Kesavanathan J, Sweitzer D, Wood RA (2000) A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge. J Allergy Clin Immunol 105:704–710. https://doi.org/10.1067/mai.2000.105123
Yoshida M, Hara N, Okuyama S (2000) Catalytic production of urethanes from amines and alkyl halides in supercritical carbon dioxide. Chem Commun 2:151–152. https://doi.org/10.1039/A908819l
Salvatore RN, Chu FX, Nagle AS, Kapxhiu EA, Cross RM, Jung KW (2002) Efficient Cs2CO3-promoted solution and solid phase synthesis of carbonates and carbamates in the presence of TBAI. Tetrahedron 58:3329–3347. https://doi.org/10.1016/S0040-4020(02)00286-7
Scriven EFV, Turnbull K (1988) Azides: their preparation and synthetic uses. Chem Rev 88:297–368. https://doi.org/10.1021/cr00084a001
Gogoi P, Konwar D (2007) An efficient modification of the Hofmann rearrangement: synthesis of methyl carbamates. Tetrahedron Lett 48:531–533. https://doi.org/10.1016/j.tetlet.2006.11.134
Cenini S, Crotti C, Pizzotti M, Porta F (1988) Ruthenium carbonyl catalyzed reductive carbonylation of aromatic nitro compounds. A selective route to carbamates. J Org Chem 53:1243–1250. https://doi.org/10.1021/jo00241a023
Salvatore RN, Ledger JA, Jung KW (2001) An efficient one-pot synthesis of N-alkyl carbamates from primary amines using Cs2CO3. Tetrahedron Lett 42:6023–6025. https://doi.org/10.1016/S0040-4039(01)01198-4
Nishtala VB, Basavoju S (2018) Crystal structure and molecular docking studies of 1-ethyl-2′-(furan-2-carbonyl)-1′-(furan-2-yl)-1′,2′,5′,6′,7′,7a′-hexahydrospiro[indoline-3,3′-pyrrolizin]-2-one. J Chem Crystallogr 48:78–90. https://doi.org/10.1007/s10870-018-0709-3(References therein)
Bauer AW, Kirby WM, Sherris JC, Turck M (1996) Antibiotic susceptibility testing by a standardized single dist method. Am J Clin Pathol 45:493–495. https://doi.org/10.1093/ajcp/45.4_ts.493
Braca A, Tommasi ND, Bari LD, Pizza C, Politi M, Morelli I (2001) Antioxidant principles from Bauhinia tarapotensis. J Nat Prod 64:892–895. https://doi.org/10.1021/np0100845
Blois MS (1958) Antioxidant determinations by the use of a stable free radical. Nature 181:1199–1200. https://doi.org/10.1038/1811199a0
Acknowledgements
S.B. thanks the Council of Scientific and Industrial Research (CSIR, India) [02(0300)/17/EMR-II] for financial support. The authors S. B. and V. B. N. thank the Director, National Institute of Technology, Warangal for providing research facilities. V. B. N. thanks the MHRD for providing research fellowship.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11030_2019_10017_MOESM1_ESM.docx
It contains the experimental section, crystal structure analysis, characterization data and copies of spectra (IR, NMR and Mass) and protocols of the biological activities (DOCX 8774 kb)
Rights and permissions
About this article
Cite this article
Nishtala, V.B., Mahesh, C., Bhargavi, G. et al. Synthesis of spirooxindolocarbamates based on Betti reaction: antibacterial, antifungal and antioxidant activities. Mol Divers 24, 1139–1147 (2020). https://doi.org/10.1007/s11030-019-10017-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-019-10017-w